Oxcarbazepine oral suspension 300 mg/5 mL
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oxcarbazepine oral suspension 300 mg/5 mL, covering 2009-08-04 to 2009-08-04. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting Conditions [NA]